Author/Authors :
Tatlısu, Mustafa Adem Dr. Siyami Ersek Cardiovascular and Thoracic Surgery Center - Cardiology Clinic, Turkey , Özcan, Serhan Dr. Siyami Ersek Cardiovascular and Thoracic Surgery Center - Cardiology Clinic, Turkey , Aruğaslan, Emre Dr. Siyami Ersek Cardiovascular and Thoracic Surgery Center - Cardiology Clinic, Turkey , Zengin, Ahmet Dr. Siyami Ersek Cardiovascular and Thoracic Surgery Center - Cardiology Clinic, Turkey , Karaca, Mehmet Dr. Siyami Ersek Cardiovascular and Thoracic Surgery Center - Cardiology Clinic, Turkey , Eren, Mehmet Dr. Siyami Ersek Cardiovascular and Thoracic Surgery Center - Cardiology Clinic, Turkey
Abstract :
Stent thrombosis is undesirable complication after percutaneous coronary interventions (PCI), despite contemporary concepts of stents and antiplatelet therapy. Stent thrombosis (ST) is defined by the Academic Research Concortium as: early ( 30 days), late (30 days to 1 year), and vey late ( 1 year). Risk of very late stent thrombosis is considerably higher in patients with drug-eluting stents (DES), owing to delayed endothelialization. There are several cases very late ST after bare-metal stent (BMS) implantation. Our patient presented with ST-elevation myocardial infarction on account of BMS thrombosis 14 years after the implantation.
NaturalLanguageKeyword :
Stent thrombosis (ST) , Drug , eluting stent (DES) , Bare , metal stent (BMS) , Percutaneous coronary intervention (PCI) , Acute Coronary syndrome (ACS)
